Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479112 · ClinicalTrials.gov registry record · NA
Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial
A NA study of Traumatic Hemorrhage, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 562
- Enrollment target
- 1
- Study location
NCT03479112 is a NA study of Traumatic Hemorrhage that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 562 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03479112, a NA study of Traumatic Hemorrhage, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 562 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled study evaluating the ability of laypersons to correctly apply a tourniquet using different instructional methods. There are four arms being evaluated: flashcards, audio-kit with visual aids, formal in person Bleeding Control Basic (B-Con) course, and a control arm. All participants will then undergo B-Con training at the end of each session and then participants will be evaluated within a 3-6 month time period to evaluate their retention of knowledge and skills taught by the B-Con course.
Conditions Studied
Interventions
- BEHAVIORAL Flashcards
- BEHAVIORAL Audio-kit
- BEHAVIORAL B-Con training
- BEHAVIORAL B-Con training retention
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 562 participants |
| Start Date | 2017-05-22 |
| Est. Completion | 2018-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03479112
The ClinicalTrials.gov registry entry for NCT03479112 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 562 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Hemorrhage appearing as the primary indexed condition, and to 4 interventions - of which Flashcards is the first listed.
NCT03479112 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03479112 about?
NCT03479112 is a clinical study titled "Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial". This is a randomized controlled study evaluating the ability of laypersons to correctly apply a tourniquet using different instructional methods. There are four arms being evaluated: flashcards, audio-kit with visual aids, formal in person Bleeding Control Basic (B-Con) course, and a control arm. Al...
What is the current status of trial NCT03479112?
This trial is currently completed. It is a NA study. The enrollment target is 562 participants. The study started on 2017-05-22. Estimated completion is 2018-01-30.
What conditions does trial NCT03479112 study?
This clinical trial studies the following conditions: Traumatic Hemorrhage.
What interventions are being tested in trial NCT03479112?
The interventions under investigation include: Flashcards (BEHAVIORAL), Audio-kit (BEHAVIORAL), B-Con training (BEHAVIORAL), B-Con training retention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03479112?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03479112 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.